Literature DB >> 30110588

Clinical Course and Management of Hypertrophic Cardiomyopathy.

Barry J Maron1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30110588     DOI： 10.1056/NEJMra1710575

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  116 in total

1.  MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.

Authors:  Jing Xu; Baiyan Zhuang; Arlene Sirajuddin; Shuang Li; Jinghan Huang; Gang Yin; Lei Song; Yong Jiang; Shihua Zhao; Minjie Lu
Journal:  Radiology       Date:  2019-11-26       Impact factor: 11.105

Review 2.  Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy.

Authors:  Angelos G Rigopoulos; Muhammad Ali; Elena Abate; Marios Matiakis; Hannes Melnyk; Sophie Mavrogeni; Dionyssios Leftheriotis; Boris Bigalke; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

3.  Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

Authors:  Martin S Maron; Ethan J Rowin; Benjamin S Wessler; Paula J Mooney; Amber Fatima; Parth Patel; Benjamin C Koethe; Mikhail Romashko; Mark S Link; Barry J Maron
Journal:  JAMA Cardiol       Date:  2019-07-01       Impact factor: 14.676

4.  Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging.

Authors:  Maria Angela Losi; Massimo Imbriaco; Grazia Canciello; Filomena Pacelli; Carlo Di Nardo; Raffaella Lombardi; Raffaele Izzo; Costantino Mancusi; Andrea Ponsiglione; Serena Dell'Aversana; Alberto Cuocolo; Giovanni de Simone; Bruno Trimarco; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2019-09-05       Impact factor: 4.132

Review 5.  Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Authors:  Manhal Habib; Sara Hoss; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

Review 6.  Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.

Authors:  Barry J Maron; Martin S Maron; Bradley A Maron; Joseph Loscalzo
Journal:  J Am Coll Cardiol       Date:  2019-04-23       Impact factor: 24.094

7.  Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?

Authors:  Leonardo Sara
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

Review 8.  Personalized medicine for cardiovascular diseases.

Authors:  Hayato Tada; Noboru Fujino; Akihiro Nomura; Chiaki Nakanishi; Kenshi Hayashi; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Hum Genet       Date:  2020-08-08       Impact factor: 3.172

Review 9.  Epidemiology of the inherited cardiomyopathies.

Authors:  William J McKenna; Daniel P Judge
Journal:  Nat Rev Cardiol       Date:  2020-09-07       Impact factor: 32.419

10.  Altered regional myocardial velocities by tissue phase mapping and feature tracking in pediatric patients with hypertrophic cardiomyopathy.

Authors:  Arleen Li; Alexander Ruh; Haben Berhane; Joshua D Robinson; Michael Markl; Cynthia K Rigsby
Journal:  Pediatr Radiol       Date:  2019-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.